RGENTA THERAPEUTICS, INC.

Profile

Company Names

RGENTA THERAPEUTICS, INC.

Addresses

300 TRADECENTER, SUITE 6600, WOBURN, MA 01801

700 MAIN STREET, CAMBRIDGE, MA 02139

Phone Numbers

781-608-3996

 

Entity Type:

CORPORATION

Industry:

OTHER

Year Incorporated:

2019

State Incorporated:

DELAWARE

Total Amount Raised:

$18,949,198.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2021-11-09 
$8,914,283.00 
$8,914,283.00 
$0.00 
Equity 
1
2020-01-21 
$10,034,915.00 
$37,999,909.00 
$27,964,994.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MARTIN 
 
HEIDECKER 
DIRECTOR
ARMAGEN TECHNOLOGIES INC   |  SENTIEN BIOTECHNOLOGIES, INC.   |  TILOS THERAPEUTICS, INC.   |  ABEXXA BIOLOGICS, INC.   |  ARMAGEN, INC.   |  RGENTA THERAPEUTICS, INC.   |  VENATORX PHARMACEUTICALS, INC.   |  VEDANTA BIOSCIENCES, INC.   |  ADAPTIVE PHAGE THERAPEUTICS, INC.   |  ELION THERAPEUTICS, INC.
JUDITH 
 
LI 
DIRECTOR
NEXTCURE, INC.   |  VERITAS GENETICS INTERNATIONAL LTD.   |  E-SCAPE BIO, INC.   |  TMUNITY THERAPEUTICS, INC.   |  INHIBRX, INC.   |  RGENTA THERAPEUTICS, INC.   |  GRITSTONE BIO, INC.   |  ADARX PHARMACEUTICALS, INC.   |  AVENZO THERAPEUTICS, INC.
SUN 
 
LINGHAO 
DIRECTOR
RGENTA THERAPEUTICS, INC.
HONGBO 
 
LU 
DIRECTOR
CROWN BIOSCIENCE, INC   |  AVEDRO INC   |  TP THERAPEUTICS, INC.   |  PERFUSE THERAPEUTICS, INC.   |  ADARX PHARMACEUTICALS, INC.   |  RGENTA THERAPEUTICS, INC.   |  VIVO OPPORTUNITY FUND, L.P.   |  ZENAS BIOPHARMA (CAYMAN) LTD   |  BLOSSOMHILL THERAPEUTICS, INC.   |  ZENAS BIOPHARMA, INC.
DEBASISH 
 
ROYCHOWDHURY 
DIRECTOR
RGENTA THERAPEUTICS, INC.
FEI 
 
SHEN 
DIRECTOR
RGENTA THERAPEUTICS, INC.   |  PROTGEN, INC.
TRAVIS 
 
WAGER 
EXECUTIVE OFFICER
RGENTA THERAPEUTICS, INC.
ZHIPING 
 
WENG 
DIRECTOR
RGENTA THERAPEUTICS, INC.
HUALIN 
SIMON 
XI 
EXECUTIVE OFFICER, DIRECTOR
RGENTA THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2022-02-07
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2021-11-09 
2021-03-12
D/A
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2020-01-21 
2020-02-05
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2020-01-21 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#